$2.58
0.000.00%
At close: -
$2.38
-0.20-7.75%
After Hours: Apr 22, 8:49 AM EDT
Comments
Loading...
Evoke Pharma Earnings Estimates, EPS & Revenue | NASDAQ:EVOK | Benzinga
Evoke Pharma reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Mar 13
EPS
$-0.490
Quarterly Revenue
$3.31M
Annual Revenue
(as of Dec 31)
(as of Dec 31)
$10.25M
Analyze the earnings history of Evoke Pharma using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| EVOK | Evoke Pharma | -$2.04 | — | — | — | $1.74M | — | — | — | 05/13/2025 | Get Alert |
| EVOK | Evoke Pharma | -$7.08 | -$0.63 | -$0.49 | 22.22% | $1.68M | $3.08M | $3.31M | 7.40% | 03/13/2025 | Get Alert |
| EVOK | Evoke Pharma | -$6.12 | -$0.38 | -$0.94 | -147.37% | $1.56M | $3.36M | $2.65M | -21.01% | 11/07/2024 | Get Alert |
| EVOK | Evoke Pharma | -$80.52 | -$0.72 | -$0.93 | -29.17% | $1.13M | $2.98M | $2.55M | -14.40% | 08/13/2024 | Get Alert |
| EVOK | Evoke Pharma | -$8.04 | -$2.52 | -$2.04 | 19.05% | $810.41K | $2.14M | $1.74M | -18.93% | 05/14/2024 | Get Alert |
| EVOK | Evoke Pharma | -$6.48 | -$6.00 | -$7.08 | -18.00% | $796.00K | $1.63M | $1.68M | 2.82% | 03/14/2024 | Get Alert |
| EVOK | Evoke Pharma | -$7.20 | -$7.44 | -$6.12 | 17.74% | $832.10K | $1.26M | $1.56M | 24.05% | 11/09/2023 | Get Alert |
| EVOK | Evoke Pharma | -$8.52 | -$8.76 | -$6.72 | 23.29% | $461.80K | $1.10M | $1.13M | 2.82% | 08/10/2023 | Get Alert |
| EVOK | Evoke Pharma | -$9.60 | -$6.96 | -$8.04 | -15.52% | $418.38K | $1.00M | $810.41K | -18.96% | 05/15/2023 | Get Alert |
| EVOK | Evoke Pharma | -$7.20 | -$6.36 | -$6.48 | -1.89% | $360.57K | $890.00K | $796.00K | -10.56% | 03/21/2023 | Get Alert |
| EVOK | Evoke Pharma | -$8.64 | -$7.92 | -$7.20 | 9.09% | $930.45K | $570.00K | $832.10K | 45.98% | 11/09/2022 | Get Alert |
| EVOK | Evoke Pharma | -$10.08 | -$7.20 | -$8.52 | -18.33% | $236.63K | $580.00K | $461.80K | -20.38% | 08/10/2022 | Get Alert |
| EVOK | Evoke Pharma | -$11.52 | -$5.76 | -$10.08 | -75.00% | $90.42K | $530.00K | $418.38K | -21.06% | 05/10/2022 | Get Alert |
| EVOK | Evoke Pharma | -$12.96 | -$11.52 | -$8.64 | 25.00% | $23.02K | $510.00K | $360.57K | -29.30% | 03/08/2022 | Get Alert |
| EVOK | Evoke Pharma | -$11.52 | -$10.08 | -$8.64 | 14.29% | $0.00 | $380.00K | $930.45K | 144.85% | 11/10/2021 | Get Alert |
| EVOK | Evoke Pharma | -$40.32 | -$11.52 | -$10.08 | 12.50% | $0.00 | $150.00K | $236.63K | 57.76% | 08/12/2021 | Get Alert |
| EVOK | Evoke Pharma | -$10.08 | -$8.64 | -$11.52 | -33.33% | $0.00 | $830.00K | $90.42K | -89.11% | 05/12/2021 | Get Alert |
| EVOK | Evoke Pharma | -$8.64 | -$18.72 | -$12.96 | 30.77% | $0.00 | $840.00K | $23.02K | -97.26% | 03/11/2021 | Get Alert |
| EVOK | Evoke Pharma | -$10.08 | — | -$11.52 | — | $0.00 | — | $0.00 | — | 11/10/2020 | Get Alert |
| EVOK | Evoke Pharma | -$12.96 | — | -$40.32 | — | $0.00 | — | $0.00 | — | 08/06/2020 | Get Alert |
| EVOK | Evoke Pharma | -$15.84 | — | -$10.08 | — | $0.00 | — | $0.00 | — | 05/12/2020 | Get Alert |
Evoke Pharma (EVOK) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q4 | 2025-03-13 | $-0.49 | $-0.63 | 22.2 % |
| Q3 | 2024-11-07 | $-0.94 | $-0.38 | -147.4 % |
| Q2 | 2024-08-13 | $-0.93 | $-0.72 | -29.2 % |
| Q1 | 2024-05-14 | $-2.04 | $-2.52 | 19.1 % |
Evoke Pharma (EVOK) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q4 | 2025-03-13 | $3.31M | $3.08M | 7.40 % |
| Q3 | 2024-11-07 | $2.65M | $3.36M | -21.0 % |
| Q2 | 2024-08-13 | $2.55M | $2.98M | -14.4 % |
| Q1 | 2024-05-14 | $1.74M | $2.14M | -18.9 % |
FAQ
When is Evoke Pharma (NASDAQ:EVOK) reporting earnings?
Evoke Pharma (EVOK) is scheduled to report earnings on May 13, 2025. The last reported earnings were for reported on March 13, 2025 for Q4.
What were the latest earnings per share (EPS) for Evoke Pharma (NASDAQ:EVOK)?
The Actual EPS was $-0.49, which beat the estimate of $-0.63.
What were Evoke Pharma’s (NASDAQ:EVOK) revenues?
The Actual Revenue was $3.3M, which beat the estimate of $3.1M.
Browse earnings estimates, EPS, and revenue on all stocks.
